Interim Phase 3 analysis of the Oxford / AstraZeneca Covid-19 vaccine candidate showed a 70.4 percent efficacy in preventing the disease, Oxford University announced on Monday. At two different dosing regimens, the vaccine, AZD1222, was 90% and 62% effective. In the most effective dosing regimen, AZD1222 was administered as a …
Read More »From India to Brazil: Astra-Oxford shooting is key to escaping pandemic in many nations
The successes of the trials by Pfizer Inc. and Moderna Inc. have fueled hopes that a Covid-19 vaccine will soon arrive. But much of the world, outside of rich nations like the United States, has the opportunity for another company to escape the crisis. Findings from the final stage of …
Read More »